Examination about the effect of the efficacy and safety by the presence or absence of the combination of romosozumab and active vitamin D3 preparatio
Not Applicable
- Conditions
- osteoporosis
- Registration Number
- JPRN-UMIN000036853
- Lead Sponsor
- Shinshu University School of Medicine Dept. of Orthopaedic Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
1:Patients who are allergic to romosozumab or eldecalcidol or alfacalcidol 2:Pregnant or breast-feeding patients 3:Hypocalcemia 4:Patients with severe renal function (eGFR 30 ml / min / 1.73 m2) or patients undergoing dialysis 5:Patients at risk of hypercalcemia (patients with renal dysfunction, patients with malignancy, patients with primary hyperparathyroidism) 6:Patients with severe liver dysfunction 7:Patients with urolithiasis and patients with a history of their history 8:Others, patients judged by the research director as inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method